ArticleACS central science2025

Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects.

Seth F Vigneron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.